The interim efficacy readout, involving around 170 participants with 15-month data, remains on track for the end of March 2026
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
The pharmaceutical giant now expects 2026 revenues to land between $59.5 billion and $62.5 billion
The launch of the study was on the occasion of the International Day of Persons with Disabilities
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
At the heart of the showdown is a deep split among federal circuit courts over whether federal law overrides state failure-to-warn claims in Roundup personal-injury suits
The proposed transaction will be effected as a share swap
Subscribe To Our Newsletter & Stay Updated
